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A B S T R A C T
Infective endocarditis is extremely rare in children with structurally normal hearts. The most common etiological
agents are staphylococcal and streptococcal species. Nutritionally variant streptococci also classiﬁed as Abiotrophia
species are a group of fastidious organisms that account for only 5% to 6% of all cases of culture-negative infective
endocarditis. Only seven cases of Abiotrophia infective endocarditis have been previously reported in children with no
underlying structural heart disease. We report two cases of Abiotrophia infective endocarditis in children without any
predisposing factors. Both patients presented with nonspeciﬁc symptoms leading to delay in diagnosis. While
bacteriological clearance was achieved in both cases, both had a complicated course including development of brain
mycotic aneurysms, splenic infarction, renal failure, and irreversible damage to the mitral valve. Both patients
required surgical removal of the native mitral valve and replacement. We also present review of seven cases with
similar diagnosis published previously in literature and highlight important differences. Our cases highlight special
challenges in management of Abiotrophia endocarditis in pediatric patients. As the organism may not be isolated in
routine culture media, may present with atypical clinical symptoms and may have a complicated course even without
antibiotic failure, a high index of suspicion should be maintained in children with subacute symptoms even with no
underlying structural cardiac disease.
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Introduction
Infective endocarditis (IE) is rare in children withan estimated incidence of 1 in 1280 admissions
per year.1 Most cases of IE occur in patients with
structural congenital or acquired heart disease
(such as rheumatic heart disease) or in the setting
of indwelling central catheters.2 IE is very rare
in children with no underlying heart disease.
Rosenthal et al. studied 85 pediatric cases of IE at a
single center. Of these, only ﬁve patients (6%) had
no known underlying heart disease or other predis-
posing factors like indwelling catheters.2 Most
cases of IE in these patients with normal hearts are
attributed to Staphylococcus aureus and Streptococcus
viridians.3–5 The term “culture-negative IE” is used
for the cases when no organism is isolated and is
seen in 5–7% of cases of IE.3,6,7 The reason for
this has been ascribed to inappropriate culture
techniques, slow-growing organisms, or organisms
that are difﬁcult to grow in regular culture media.8
Abiotrophia species previously classiﬁed as nutri-
tionally variant streptococci (NVS) is one such
fastidious organism that has been reported as a rare
cause (5–6% of all cases) of culture-negative IE.9–12
This organism has been reported to be associated
with high relapse rates and treatment failures in
adults.9,11 The infection is rare in childrenwith only
17 reported cases in the worldwide literature.10,13
Of these, only seven have been reported in children
with no underlying structural heart disease.11–16 We
report two cases of IE in children with structurally
normal hearts caused by Abiotrophia species and
their outcomes and review of other published cases.
Case Report 1
An 11-year-old previously healthy boy was admit-
ted with a 5-month history of recurrent migratory
arthralgia. His initial symptoms were right ankle
pain, which transiently improved with steroids fol-
lowed by pain in the joints of hands and feet. The
joint symptoms were preceded by streptococcal
throat infection which was treated with two
courses of antibiotics. There was no associated
history of fever, rash, chest pain, exertional
dyspnea, or syncope. The medical history was
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insigniﬁcant for any cardiac, dental, or systemic
disease requiring indwelling central catheters.
On initial examination, he was afebrile (tem-
perature 36.4°C) with tachycardia (heart rate 123/
minute), mildly elevated blood pressure (124/
79 mm Hg), and saturations of 99% on room air.
Positive ﬁndings on examination included mild
edema and redness of the right ankle joint and a
grade 3/6 holosystolic murmur which was heard
best in the axilla. His initial laboratory evaluation
showed elevated C-reactive protein (90 mg/L),
erythrocyte sedimentation rate (42 mm/hour), and
rheumatoid factor (156 IU/mL). He had normal
levels of anti-streptococcal DNAase titers (1:480),
anti-streptococcal O titers (141 IU/mL), immuno-
globulins, and complements. Magnetic resonance
imaging of the lower limb joints showed no effu-
sions or bony lesions. An echocardiogram showed
moderate mitral insufﬁciency, no mitral valve
stenosis with normal Doppler velocities in all
other valves. No obvious vegetations were visual-
ized on any valves. The biventricular function was
normal with no evidence of pericardial effusion. A
provisional diagnosis of IE was made and he was
started on vancomycin and ceftriaxone.
The blood cultures drawn before the start of
antibiotics remained negative for 3 days and then
showed growth of the rare Abiotrophia species.
Drug sensitivity patterns could not be assessed on
this pathogen due to its fastidious growth require-
ments. He was then switched to ampicillin and
gentamicin as empiric therapy for NVS as recom-
mended by the infectious disease team. He under-
went a repeat echocardiogram on day 7, which
now showed a 9 mm ¥ 9 mm vegetation on the
superior surface of both the leaﬂets of mitral valve
with moderate mitral regurgitation. Blood culture
showed no growth after day 7 of treatment.
Patient remained asymptomatic from the cardio-
vascular standpoint and was discharged home after
14 days on home intravenous antibiotics.
A week after discharge, he presented with high-
grade fever (39.5°C) and generalized headaches. A
magnetic resonance imaging scan of the brain
revealed a 5.5-mm aneurysm involving the ante-
rior opercular branch of the left middle cerebral
artery with evidence of adjacent vasculitis
(Figure 1). The aneurysms were managed conser-
vatively with observation. Vancomycin was added
in place of ampicillin. The repeat serial blood cul-
tures showed no growth. His fever and headache
resolved over the next 2 days and he was dis-
charged home on vancomycin and gentamicin.
Three days later, patient returned with complaints
of severe left upper quadrant abdominal pain. An
urgent abdominal computed tomography with
contrast showed an infarcted area within the ante-
rior spleen. He had no associated hemodynamic
instability and was managed conservatively. At
this time, his laboratory tests demonstrated acute
deterioration of renal function with increase in
creatinine (9 mg/dL) with hyponatremia (sodium:
129 meq/L). He was diagnosed with nonoliguric
renal failure which was thought to be related to a
combination of endocarditis, nephro-toxic drugs,
and intravenous contrast. Gentamicin was discon-
tinued and he was continued on vancomycin
monotherapy. His blood cultures remained nega-
tive. His renal function was monitored closely and
gradually normalized.
His follow-up echocardiogram after completing
6 weeks of antibiotics showed no change in size of
vegetations or severity of mitral valve regurgita-
tion. Considering the high risk for intracranial
bleeding, aneurysm rupture, or embolization, sur-
gical replacement of the mitral valve was withheld.
He subsequently underwent coil occlusion of his
brain aneurysm. At 10 months follow-up, his
echocardiogram showed signiﬁcant mitral valve
regurgitation, and he was therefore referred for
Figure 1. Magnetic resonance image of the brain in the
first patient shows mycotic aneurysm in the left middle cere-
bral artery.
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surgery. During the surgery, he was found to have
diffusely damaged valve leaﬂets and therefore
underwent mechanical mitral valve replacement.
He was clinically doing well at 6 months follow up
after surgery.
Case Report 2
A 14-year-old previously healthy girl was admitted
with 1-year history of recurrent cough, myalgia,
and arthralgia. Her symptoms were preceded by
removal of orthodontic braces. These episodes
had been treated with several short courses of anti-
biotics and analgesics.
On initial examination, she was afebrile (tem-
perature 37.3°C) with normal heart rate (88 beats/
minute), blood pressure (97/58 mm Hg), and
saturations (98% room air). Positive ﬁndings on
examination included digital clubbing and a
medium-pitched grade 3/6 holosystolic murmur
which was best heard in the mitral area with radia-
tion to the axilla. Her initial laboratory workup
showed mild anemia (hemoglobin 11.6 gm/dL),
elevated erythrocyte sedimentation rate (16 mm/
hour), and rheumatoid factor (8.9 IU/mL). An
echocardiogram revealed a long, thread-like veg-
etation on the anterior mitral leaﬂet with moder-
ate to severe mitral valve insufﬁciency (Figure 2).
All other valves were normal. The left atrium and
ventricle were mildly dilated. The biventricular
function was normal with no evidence of pericar-
dial effusion.
She was empirically started on ampicillin and
gentamicin as treatment for IE. Her blood culture
showed growth of Abiotrophia species after 3 days
of incubation which was found to be resistant to
ceftriaxone but sensitive to penicillin, meropenem,
and vancomycin. She was continued on the same
antibiotics. The ﬁrst ﬁve blood cultures drawn on
the ﬁrst day were positive, and subsequently, she
had serial negative blood cultures. On day 10, she
developed fever when she was switched to vanco-
mycin; however, her repeat blood culture did not
show any growth. She was discharged home after
17 days with a planned 6-week course of intrave-
nous antibiotics.
Her follow-up echocardiogram after 4 weeks
of treatment showed a decrease in the size of the
vegetation while she continued to have moderate
to severe mitral insufﬁciency. About 4 months
after completing her antibiotic treatment, she was
referred for surgery. During surgery, the anterior
leaﬂet of the mitral valve was noted to be severely
damaged, and the posterior leaﬂet was half the
size of normal. A mitral valve replacement with
mechanical valve was performed. The postopera-
tive course was complicated by development of
complete heart block which required placement of
a permanent pacemaker. She was discharged home
after 10 days. She was clinically doing well at 6
months follow up after surgery.
Discussion
IE is rare in children without underlying heart
disease.2 Rosenthal et al. studied 85 pediatric cases
of IE at a single center. Of these, only ﬁve patients
(6%) had no known underlying heart disease or
other predisposing factors like indwelling cath-
eters.2 Most cases of IE in these patients with
normal hearts are attributed to S. aureus and
S. viridians.3–5 IE caused by Abiotrophia species is
extremely rare in children, with only 17 reported
cases in the worldwide literature.10,13,17 Of these,
nine had a structural heart disease and one was a
neutropenic patient with long-term indwelling
catheters.17 So far, only seven cases of Abiotrophia
endocarditis have been reported in children
with no underlying structural heart disease
(Table 1).11–16 We report two pediatric cases of
Abiotrophia endocarditis which highlight some
important distinctive features of this rare infec-
tion. Both our patients were previously healthy
with no underlying heart disease or predisposing
factors such as central catheters. Both presented
with atypical symptoms including migratory
arthralgia, nonspeciﬁc fatigue, and absence of
fever. The organism showed delayed growth, and
drug sensitivity patterns could not be assessed due
Figure 2. Transthoracic echocardiogram performed on the
second patient shows thread-like vegetation on the anterior
mitral valve leaflet.
Bhat et al.E118
Congenit Heart Dis. 2014;9:E116–E120
to its fastidious growth requirements. Importantly,
bacterial clearance was achieved in both patients
within a week of appropriate treatment. Neverthe-
less, one of them had a complicated course with
embolic brain aneurysms and splenic infarct.
Mitral valve function was severely affected in both
patients, necessitating surgical replacement and
need for lifelong anticoagulation.
Abiotrophia species belong to the genus of NVS
which are a group of fastidious nonhemolytic
streptococci that were ﬁrst isolated in 1961 by
Frenkel and Hirsch from patients with endocardi-
tis and otitis media.18 The NVS are estimated to
be responsible for about 5% to 6% of cases of
culture-negative endocarditis.12,19,20 These patho-
gens are called “nutritionally variant” because they
require addition of 0.01% L-cysteine or 0.001%
pyridoxal to ordinary culture media for their
growth.15 Bouvet et al. further classiﬁed the NVS
into two species, Streptococcus adjacens and Strepto-
coccus defectiva, based on DNA-DNA hybridization
technique.21 These two species together constitute
the genus Abiotrophia, which consists of the species
Abiotrophia defective and Abiotrophia adiacens.22
Abiotrophia endocarditis has been rarely
reported in children. Chang et al. reviewed 13
cases of IE caused by NVS in children reported in
English literature since 1971.10 Nine of these
patients (69%) had some underlying heart disease.
We performed a review of the literature and found
that only seven pediatric patients with no struc-
tural heart disease have been previously reported
(Table 1).11–16 Five of these patients (71%) were
managed with antibiotics alone and only two
(29%) patients required surgical replacement of
the valve due to severe mitral regurgitation and
aortitis, respectively. This is in contrast to our two
patients who both required surgical valve replace-
ment, necessitating lifelong anticoagulation.
Several studies in adults have reported high
rates of complications in Abiotrophia endocarditis
including bacteriological failure rate up to 40%,
mortality rates of 17–20% from congestive cardiac
failure, and embolization in up to 27% of
cases.7,23,24 This has been attributed to difﬁculty in
isolating this organism and high drug resistance
rates. In contrast, both our patients achieved rela-
tively rapid bacteriological clearance. Despite this,
both our patients had complicated course, with
our ﬁrst patient developing embolic mycotic aneu-
rysms in cerebral vessels. Only three cases of
mycotic aneurysms have been previously reported
secondary to Abiotrophia endocarditis.25–27 All three
of these were adults and two had subarachnoid
hemorrhages. To the authors’ knowledge, our ﬁrst
patient is the ﬁrst pediatric case of multiorgan
embolization due to mitral valve Abiotrophia
endocarditis without antibiotic bacteriological
failure.
Our cases highlight special challenges in the
management of Abiotrophia endocarditis in pediat-
ric patients. Despite appropriate antibiotic therapy
and achievement of bacteriological clearance,
patients are at high risk for embolic and immune-
mediated complications and irreversible valve
damage. These patients require close monitoring
and early involvement of surgical team for man-
agement. As the organism may not be isolated in
routine culture media, and may present with atypi-
cal clinical symptoms, a high index of suspicion
should be maintained in children with subacute
symptoms even with no underlying heart disease.
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Table 1. Review of Seven Cases of Abiotrophia Endocarditis Reported in Children with No Known Underlying Structural
Heart Disease or Indwelling Catheter
Serial Number Author, Year Age (Years)/Sex Course and Complications Treatment
1 Cayeux et al., 197115 14/M Mitral regurgitation Surgical valve replacement
2 Roberts and Sidlak, 197912 13/F No relapse Medical
3 Feder et al., 198016 7/M Relapse Medical
4 Feder et al., 198016 16/F Relapse Medical
5 Handrick et al., 198814 11/F No relapse Medical
6 Raff et al., 200413 5/M Aortitis, cardiac arrest Surgical valve replacement
7 Lin and Hsu, 200711 12/F No relapse at 68 months Medical
Present case 1 11/M Brain mycotic aneurysm, splenic infarction,
glomerulonephritis
Surgical valve replacement
Present case 2 14/F Severe mitral regurgitation Surgical valve replacement
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